Tyrphostin AG 538, a specific inhibitor of the IGF1R tyrosine kinase (TKI), was used to confirm the contribution of IGF1R in IGF-II-stimulated fibrosis in NL and SSc (Fig 3E). The gene discussed is IGF2; the disease is systemic sclerosis.